关注
Clovis BOIBESSOT
Clovis BOIBESSOT
Biomarker strategy lead, Servier
在 servier.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Sex steroids in the tumor microenvironment and prostate cancer progression
C Boibessot, P Toren
Endocrine-Related Cancer 25 (3), R179-R196, 2018
372018
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
C Boibessot, O Molina, G Lachance, C Tav, A Champagne, B Neveu, ...
Clinical and translational medicine 12 (1), e581, 2022
162022
Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs
C Boibessot, FH Joncas, A Park, Z Berrehail, JF Pelletier, T Gris, ...
Scientific Reports 11 (1), 19299, 2021
92021
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
N Janikashvili, C Gérard, M Thébault, A Brazdova, C Boibessot, ...
Oncoimmunology 10 (1), 1880046, 2021
92021
Sex steroid modulation of macrophages within the prostate tumor microenvironment
Z Berrehail, C Boibessot, T Gris, FH Joncas, F Gaignier, C Guillemette, ...
American Journal of Clinical and Experimental Urology 10 (2), 98, 2022
22022
Caractérisation du dialogue entre macrophages et cellules cancéreuses dans le microenvironnement tumoral du cancer de la prostate
C Boibessot
Université Laval, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–6